NeoGenomics, Inc. (NEO) is a publicly traded Healthcare sector company. As of May 21, 2026, NEO trades at $8.85 with a market cap of $1.09B and a P/E ratio of 0.00. NEO moved +6.08% today. Year to date, NEO is -26.32%; over the trailing twelve months it is +11.39%. Its 52-week range spans $4.72 to $19.12. Analyst consensus is buy with an average price target of $14.94. Rallies surfaces NEO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for NEO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $8.85 |
| Market Cap | $1.09B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.12 |
| 52-Week Low | $4.72 |
| Volume | 4.23K |
| Avg Volume | 0 |
| Revenue (TTM) | $727.33M |
| Net Income | $-108.03M |
| Gross Margin | 43.21% |
11 analysts cover NEO: 0 strong buy, 8 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.94.